Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Eva Hoster, Ulrich Mey et al.|The Lancet|2024Cited by 135
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in SwitzerlandAlden A. Moccia, Felicitas Hitz, Stefanie Aeppli et al.|Hematological Oncology|2020Cited by 15
<sup>161</sup>Tb Radioimmunotherapy as a Treatment for CD30-Positive LymphomasElisa Rioja-Blanco, Martin Béhé, Yara Banz et al.|Journal of Nuclear Medicine|2025Cited by 8